Société AroCell AB (publ) Nasdaq Stockholm
Actions
SE0003883990
Recherche biotechnologique et médicale
Métier
Ventes par activité
SEK en Millions | 2020 | Poids | 2021 | Poids | Delta |
---|---|---|---|---|---|
Research and Development in Cell Biology and Medicine
100,0
%
| 0 | 100,0 % | 12 | 100,0 % | +14 180,95% |
Ventes par région
SEK en Millions | 2020 | Poids | 2021 | Poids | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 0 | 100,0 % | 12 | 100,0 % | +14 180,95% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Anders Hultman
CEO | Chief Executive Officer | 50 | 01/12/18 |
Lars Jakobsson
DFI | Director of Finance/CFO | 67 | - |
Gustav Sten
COO | Chief Operating Officer | - | 01/01/19 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Chief Tech/Sci/R&D Officer | - | 01/01/15 | |
Alona Nyberg
IRC | Investor Relations Contact | - | 01/01/19 |
Gunnar Wahlberg
SAM | Sales & Marketing | 54 | 01/01/21 |
Tina Yang
PRN | Corporate Officer/Principal | - | 01/01/17 |
Peter Lowendahl
LAW | General Counsel | - | 01/01/19 |
Filip Fogdestam
PRN | Corporate Officer/Principal | - | 01/01/14 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 65 | 01/01/22 | |
Director/Board Member | 63 | 01/05/21 | |
Clas Runnberg
BRD | Director/Board Member | 72 | 01/01/23 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Max Pihlqvist
BRD | Director/Board Member | 37 | 01/01/22 |
Eva Nordström
BRD | Director/Board Member | 54 | 01/01/20 |
Director/Board Member | - | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 230 361 066 | 102 183 486 ( 44,36 %) | 0 | 44,36 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+17,96% | 44,96 Md | |
+1,17% | 42,65 Md | |
+48,77% | 41,85 Md | |
-4,27% | 29,04 Md | |
+11,42% | 26,08 Md | |
-21,39% | 19,03 Md | |
+4,86% | 12,75 Md | |
+27,29% | 12,06 Md | |
-3,50% | 11,75 Md |